Study Shows Trust is still at Heart of NHS COVID App Reluctance

A new study has shown that issues surrounding trust are still at the heart of people's reluctance to download and use the NHS App, particularly among Black, Asian and minority ethnic (BAME) communities.

Researchers from the University of Nottingham's Horizon Digital Research Institute and the Trustworthy Autonomous Systems (TAS) Hub undertook a survey of over 1,000 people and found that while compliance on the part of the approximately 50% of participants who had the app was fairly high, there were issues surrounding trust and understanding that hindered adoption and, therefore, the effectiveness of digital contact tracing, particularly among BAME communities. Their findings have been published in the Journal of Medical Internet Research.

The study involved a nationally representative sample of 16-75 year olds across the UK and took place in December 2020, around 3 months after the app was released.

Results showed that those who chose not to use the app had lower levels of trust, more negative views and less understanding of the app. BAME participants had particularly negative views and were more likely to delete the app. These views include lower trust in the NHS.

Older adults, who are also likely to be more seriously affected by the virus, had more positive views but were also less likely to download the app in the first place. The study also showed that although the intention to follow advice to self-isolate was high, compliance among those who had actually been notified by the app was lower.

Dr Liz Dowthwaite led the study and explains: "This study has revealed a number of issues around trust and compliance, in particular around being notified to self-isolate. Whilst we did not delve into the reasons for this, it may have something to do with the impersonal nature of the app - participants told us they felt it was important that they could verify and get explanations for notifications, as well as that they could speak to a person about what the app told them."

Among the 27.4% of participants who did not intend to download the app, the most common reasons were a desire not to be tracked, not thinking it would be effective, not wanting to take part in contact tracing in that way, and lack of trust in those who built the app. Of the 8.4% who had decided to delete the app, this was mostly because they did not think it was effective or did not want to be tracked.

Liz added: "The findings have implications for the future use of mobile applications for public health; in order to be effective such apps need to be accepted and used by the vast majority of society, and we have seen from this study that there are particular issues in uptake among those most likely to be negatively affected. We believe that It is extremely important to engage the potential users of such technologies at the design stages of these technologies, to identify barriers to use before they are released, in order to enhance uptake."

Dowthwaite L, Fischer J, Perez Vallejos E, Portillo V, Nichele E, Goulden M, McAuley D.
Public Adoption of and Trust in the NHS COVID-19 Contact Tracing App in the United Kingdom: Quantitative Online Survey Study.
J Med Internet Res 2021;23(9):e29085. doi: 10.2196/29085

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...